(Q83586602)
Statements
Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences (English)
Bruno Fautrel
Francis Guillemin
Olivier Meyer
Michel de Bandt
Jean-Marie Berthelot
René-Marc Flipo
Jean-Francis Maillefert
Daniel Wendling
Alain Saraux
Xavier Le Loët
Stratégies Thérapeutiques dans La Polyarthrite RhumatoIde Working Group
Club Rhumatismes et Inflammation
French Society of Rheumatology